UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
| (Mark One) | |
ý |
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
For the period ended September 30, 2002. |
|
o |
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
Commission File Number: 0-20289
KEMET CORPORATION
Exact name of registrant as specified in its charter
| DELAWARE | 57-0923789 | |
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
|
2835 KEMET WAY, SIMPSONVILLE, SOUTH CAROLINA 29681 (Address of principal executive offices, zip code) |
||
864-963-6300 (Registrant's telephone number, including area code) |
||
Former name, former address and former fiscal year, if changed since last report: N/A
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o
Common Stock Outstanding at: October 31, 2002
| Title of Each Class |
Number of Shares Outstanding |
|
|---|---|---|
| Common Stock, $.01 Par Value | 86,188,257 |
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(Dollars in thousands except per share data)
| |
September 30, 2002 |
March 31, 2002 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | $ | 235,323 | $ | 234,622 | ||||||
| Accounts receivable | 49,083 | 22,101 | ||||||||
| Inventories: | ||||||||||
| Raw materials and supplies | 97,191 | 118,527 | ||||||||
| Work in process | 57,502 | 68,318 | ||||||||
| Finished goods | 62,263 | 72,547 | ||||||||
| Total inventories | 216,956 | 259,392 | ||||||||
| Income taxes receivable | 5,942 | | ||||||||
| Prepaid expenses and other current assets | 8,713 | 10,791 | ||||||||
| Deferred income taxes | 21,475 | 40,255 | ||||||||
| Total current assets | 537,492 | 567,161 | ||||||||
| Property and equipment, net | 508,831 | 539,785 | ||||||||
| Intangible assets, net | 42,039 | 41,856 | ||||||||
| Other assets | 23,182 | 22,912 | ||||||||
| Total assets | $ | 1,111,544 | $ | 1,171,714 | ||||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||||
| Current liabilities: | ||||||||||
| Accounts payable, trade | $ | 24,446 | $ | 73,057 | ||||||
| Accrued expenses | 37,991 | 32,252 | ||||||||
| Income taxes payable | | 7,076 | ||||||||
| Total current liabilities | 62,437 | 112,385 | ||||||||
| Long-term debt | 100,000 | 100,000 | ||||||||
| Other non-current obligations | 48,925 | 48,926 | ||||||||
| Deferred income taxes | 55,708 | 55,358 | ||||||||
| Total liabilities | 267,070 | 316,669 | ||||||||
Stockholders' equity: |
||||||||||
| Common stock, par value $.01, authorized 300,000,000 shares, issued 87,822,527 and 87,783,060 shares at September 30, 2002, and March 31, 2002, respectively | 878 | 878 | ||||||||
| Additional paid-in capital | 321,924 | 321,734 | ||||||||
| Retained earnings | 555,176 | 562,903 | ||||||||
| Accumulated other comprehensive income (loss) | (3,050 | ) | 3,808 | |||||||
| Treasury stock, at cost (1,652,185 and 1,859,695 shares at September 30, 2002, and March 31, 2002, respectively) | (30,454 | ) | (34,278 | ) | ||||||
| Total stockholders' equity | 844,474 | 855,045 | ||||||||
Commitments and contingencies |
||||||||||
Total liabilities and stockholders' equity |
$ |
1,111,544 |
$ |
1,171,714 |
||||||
See accompanying notes to consolidated financial statements.
2
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
(Dollars in thousands except per share data)
| |
Three months ended September 30, |
Six months ended September 30, |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
2002 |
2001 |
||||||||||||
| Net sales | $ | 113,055 | $ | 120,636 | $ | 237,100 | $ | 273,357 | ||||||||
Operating costs and expenses: |
||||||||||||||||
| Cost of goods sold | 96,710 | 98,296 | 197,663 | 208,831 | ||||||||||||
| Selling, general and administrative expenses | 13,293 | 13,524 | 27,150 | 27,572 | ||||||||||||
| Research and development | 6,936 | 6,653 | 13,715 | 14,353 | ||||||||||||
| Restructuring and impairment charges | 16,964 | | 16,964 | | ||||||||||||
| Total operating costs and expenses | 133,903 | 118,473 | 255,492 | 250,756 | ||||||||||||
| Operating income (loss) | (20,848 | ) | 2,163 | (18,392 | ) | 22,601 | ||||||||||
Other (income) and expense: |
||||||||||||||||
| Interest income | (1,013 | ) | (2,521 | ) | (1,951 | ) | (6,622 | ) | ||||||||
| Interest expense | 553 | 1,998 | 2,100 | 4,018 | ||||||||||||
| Other expense (income) | (3,496 | ) | 1,139 | (6,834 | ) | 3,266 | ||||||||||
| Total other expense (income) | (3,956 | ) | 616 | (6,685 | ) | 662 | ||||||||||
Earnings (loss) before income taxes |
(16,892 |
) |
1,547 |
(11,707 |
) |
21,939 |
||||||||||
Income tax expense (benefit) |
(5,743 |
) |
557 |
(3,980 |
) |
7,898 |
||||||||||
| Net earnings (loss) | $ | (11,149 | ) | $ | 990 | $ | (7,727 | ) | $ | 14,041 | ||||||
Net earnings (loss) per share: |
||||||||||||||||
| Basic | $(0.13 | ) | $0.01 | $(0.09 | ) | $0.16 | ||||||||||
| Diluted | $(0.13 | ) | $0.01 | $(0.09 | ) | $0.16 | ||||||||||
Weighted-average shares outstanding: |
||||||||||||||||
| Basic | 86,163,766 | 85,653,867 | 86,120,855 | 85,733,303 | ||||||||||||
| Diluted | 86,163,766 | 86,399,931 | 86,120,855 | 86,577,400 | ||||||||||||
See accompanying notes to consolidated financial statements.
3
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Dollars in thousands)
| |
Six months ended September 30, |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
||||||||
| Sources (uses) of cash: | ||||||||||
Operating activities: |
||||||||||
| Net earnings (loss) | $ | (7,727 | ) | $ | 14,041 | |||||
| Adjustments to reconcile net earnings to net cash from operating activities: | ||||||||||
| Depreciation, amortization and impairment charges | 41,303 | 37,532 | ||||||||
| Change in operating assets | 16,827 | 39,814 | ||||||||
| Change in liabilities | (43,396 | ) | (155,071 | ) | ||||||
| Tax benefit on stock options exercised | 709 | 414 | ||||||||
| Net cash provided (used) by operating activities | 7,716 | (63,270 | ) | |||||||
Investing activities: |
||||||||||
| Purchases of short-term investments | (14,959 | ) | (47,895 | ) | ||||||
| Proceeds from maturity of short-term investments | 14,959 | | ||||||||
| Additions to property and equipment | (11,081 | ) | (63,297 | ) | ||||||
| Investment in affiliates | (113 | ) | (7,207 | ) | ||||||
| Other | 875 | 176 | ||||||||
| Net cash used by investing activities | (10,319 | ) | (118,223 | ) | ||||||
Financing activities: |
||||||||||
| Proceeds from sale of common stock to Employee Savings Plan | 665 | 840 | ||||||||
| Proceeds from exercise of stock options | 2,639 | 366 | ||||||||
| Proceeds from put options | | 600 | ||||||||
| Purchases of treasury stock | | (10,800 | ) | |||||||
| Net cash provided (used) by financing activities | 3,304 | (8,994 | ) | |||||||
Net increase (decrease) in cash |
701 |
(190,487 |
) |
|||||||
Cash and cash equivalents at beginning of period |
234,622 |
360,758 |
||||||||
Cash and cash equivalents at end of period |
$ |
235,323 |
$ |
170,271 |
||||||
See accompanying notes to consolidated financial statements.
4
Note 1. Basis of Financial Statement Preparation
The consolidated financial statements contained herein, other than the March 31, 2002, balance sheet, are unaudited and have been prepared from the books and records of KEMET Corporation and its Subsidiaries ("KEMET" or the "Company"). In the opinion of management, the consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. The consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. Although the Company believes that the disclosures are adequate to make the information presented not misleading, it is suggested that these consolidated financial statements be read in conjunction with the audited financial statements and notes thereto included in the Company's fiscal year ending March 31, 2002, Form 10-K. Net sales and operating results for the three and six month periods ended September 30, 2002, are not necessarily indicative of the results to be expected for the full year.
The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. In consolidation, all significant intercompany amounts and transactions have been eliminated.
When KEMET Electronics Corporation was formed as a separate entity in 1987, it continued the Union Carbide practice of expensing depreciation and amortization costs in the current period, rather than including such costs as a component of inventory and expensing them through cost of goods sold over time, as required by current generally accepted accounting principles. Beginning with the June 2002 quarter, KEMET included depreciation and amortization as a component of its cost of inventory. The impact of this change on the three month and six month periods ended September 30, 2002, amounted to additional after-tax income of approximately $243,000 and $385,000 or $0.003 and $0.004 per share, respectively. KEMET has also reviewed the financial statements contained in its previously filed 2002 Annual Report on Form 10-K and confirmed that this change would not have resulted in any material changes to those financial statements. In addition, the presentation of the Income Statement has been reclassified to include depreciation and amortization expenses of $15.2 million and $15.9 million in cost of goods sold; depreciation of $2.0 million and $1.9 million in selling, general, and administrative expenses; and depreciation of $0.4 million and $0.3 million in research and development expenses in the quarters ended September 30, 2002 and 2001, respectively, and depreciation and amortization expenses of $31.0 million and $32.0 million in cost of goods sold; depreciation of $4.0 million and $3.8 million in selling, general, and administrative expenses; and depreciation of $0.7 million and $0.5 million in research and development expenses in the six month periods ended September 30, 2002 and 2001, respectively.
This change makes KEMET's financial statement presentation more comparable to those of other capacitor manufacturers.
The Company also converted the cost of a portion of its inventory determined by the last-in, first-out ("LIFO") basis to the first-in, first-out ("FIFO") method during the quarter ended June 30, 2002. The after-tax impact was approximately $544,000 and was not considered material to the consolidated financial statements. Therefore, prior period amounts have not been restated for this change in accounting principle. LIFO was the basis for approximately 6% of inventory costs of certain raw materials at March 31, 2002. After the conversion, 100% of the Company's inventory costs will be determined by the FIFO method.
See also Note 3.
Certain prior-year amounts were reclassified to conform to current period presentation.
5
Note 2. Reconciliation of basic earnings per common share to diluted earnings per common share
In accordance with FASB Statement No. 128, the Company has included the following table presenting a reconciliation of basic earnings per share (EPS) to diluted earnings per share fully displaying the effect of dilutive securities.
Computation of Basic and Diluted Earnings (Loss) Per Share
(Dollars in thousands except per share data)
| |
For the three months ended September 30, |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
|||||||||||||||
| |
Loss (numerator) |
Shares (denominator) |
Per Share Amount |
Income (numerator) |
Shares denominator |
Per Share Amount |
|||||||||||
| Basic EPS | $ | (11,149 | ) | 86,163,766 | $ | (0.13 | ) | $ | 990 | 85,653,867 | $ | 0.01 | |||||
Effect of dilutive securities: |
|||||||||||||||||
| Stock options | | | | | 698,972 | | |||||||||||
| Put options | | | | | 47,092 | | |||||||||||
| Diluted EPS | $ | (11,149 | ) | 86,163,766 | $ | (0.13 | ) | $ | 990 | 86,399,931 | $ | 0.01 | |||||
For the six months ended September 30, |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
|||||||||||||||
| |
Loss (numerator) |
Shares (denominator) |
Per Share Amount |
Income (numerator) |
Shares denominator |
Per Share Amount |
|||||||||||
| Basic EPS | $ | (7,727 | ) | 86,120,855 | $ | (0.09 | ) | $ | 14,041 | 85,733,303 | $ | 0.16 | |||||
Effect of dilutive securities: |
|||||||||||||||||
| Stock options | | | | | 798,996 | | |||||||||||
| Put options | | | | | 45,101 | | |||||||||||
| Diluted EPS | $ | (7,727 | ) | 86,120,855 | $ | (0.09 | ) | $ | 14,041 | 86,577,400 | $ | 0.16 | |||||
The quarter and six months ended September 30, 2002, excluded potentially dilutive securities of 482,817 and 632,802, respectively, in the computation of diluted earnings per share because the effect would have been anti-dilutive.
Note 3. Goodwill and intangible assets
In July 2001, the FASB issued Statement of Financial Accounting Standards No. 141, "Business Combinations" (Statement No. 141), and Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets" (Statement No. 142). Statement No. 141 requires that the purchase method of accounting be used for all business combinations initiated after June 30, 2001. Statement No. 141 also specifies criteria that intangible assets acquired in a purchase method business combination must meet in order to be recognized and reported apart from goodwill. Statement No. 142 requires that goodwill and intangible assets with indefinite useful lives no longer be amortized, but instead be tested for impairment. In addition, any unamortized negative goodwill must be written off at the date of adoption. Statement No. 142 is effective for fiscal years beginning after December 15, 2001, and was adopted by the Company effective April 1, 2002.
In connection with the adoption of Statement No. 142, the Company completed impairment tests of its goodwill and other identifiable intangible assets including indefinite-lived trademarks, as well as patents and technology that have definite lives and will continue to be amortized. No impairment of assets was noted.
6
For purposes of determining the fair value of its trademarks, the Company utilized a discounted cash flow model which considered the costs of royalties in the absence of trademarks owned by the Company.
For purposes of determining potential impairment of goodwill, the Company aggregated its reporting units as its segments are aggregated to a single reporting segment under Statement No. 131. The Company's publicly traded stock price is utilized as a component of its model for determining fair value in order to evaluate goodwill impairment. Negative goodwill of approximately $661,000 was written off upon adoption of the new standard and was included in "Other income" in the statement of earnings for the quarter ended June 30, 2002, because it was not material.
The carrying amounts, accumulated amortization, and amortization expense for each of the periods presented are noted below by intangible asset class (in thousands):
| |
September 30, 2002 |
March 31, 2002 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
Carrying Amount |
Accumulated Amortization |
Carrying Amount |
Accumulated Amortization |
|||||||||
| Goodwill | $ | 41,630 | $ | 13,278 | $ | 41,630 | $ | 13,278 | |||||
| Negative goodwill | | | (921 | ) | (260 | ) | |||||||
| Trademarks | 10,000 | 2,819 | 10,000 | 2,819 | |||||||||
| Patents and technology | 12,000 | 6,011 | 12,000 | 5,611 | |||||||||
| Other | 1,142 | 625 | 1,143 | 548 | |||||||||
| $ | 64,772 | $ | 22,733 | $ | 63,852 | $ | 21,996 | ||||||
Amortization Expense |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
Three months ended September 30, |
Six months ended September 30, |
|||||||||||
| |
2002 |
2001 |
2002 |
2001 |
|||||||||
| Goodwill | $ | | $ | 247 | $ | | $ | 493 | |||||
| Negative goodwill | | (6 | ) | | (12 | ) | |||||||
| Trademarks | | 63 | | 125 | |||||||||
| Patents and technology | 200 | 200 | 400 | 400 | |||||||||
| Other | 59 | 39 | 78 | 79 | |||||||||
| $ | 259 | $ | 543 | $ | 478 | $ | 1,085 | ||||||
7
The reconciliation of net income and earnings per share, adjusted to exclude goodwill, trademark, and negative goodwill amortization expense, net of tax, for the three and six month periods ended September 30, 2001, is as follows (in thousands, except per share amounts):
| |
Three months ended September 30, |
Six months ended September 30, |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
2002 |
2001 |
||||||||||
| Net income(loss): | ||||||||||||||
| Reported net income (loss) | $ | (11,149 | ) | $ | 990 | $ | (7,727 | ) | $ | 14,041 | ||||
| Goodwill amortization, net of tax | | 158 | | 315 | ||||||||||
| Negative goodwill amortization, net of tax | | (4 | ) | | (7 | ) | ||||||||
| Trademark amortization, net of tax | | 40 | | 80 | ||||||||||
| Adjusted net income (loss) | $ | (11,149 | ) | $ | 1,184 | $ | (7,727 | ) | $ | 14,429 | ||||
Basic earnings (loss) per common share: |
||||||||||||||
| Reported basic earnings (loss) per common share | $ | (0.13 | ) | $ | 0.01 | $ | (0.09 | ) | $ | 0.16 | ||||
| Goodwill amortization, net of tax | | 0.00 | | 0.01 | ||||||||||
| Negative goodwill amortization, net of tax | | 0.00 | | 0.00 | ||||||||||
| Trademark amortization, net of tax | | 0.00 | | 0.00 | ||||||||||
| Adjusted basic earnings (loss) per common share | $ | (0.13 | ) | $ | 0.01 | $ | (0.09 | ) | $ | 0.17 | ||||
Diluted earnings (loss) per common share: |
||||||||||||||
| Reported diluted earnings (loss) per common share | $ | (0.13 | ) | $ | 0.01 | $ | (0.09 | ) | $ | 0.16 | ||||
| Goodwill amortization, net of tax | | 0.00 | | 0.01 | ||||||||||
| Negative goodwill amortization, net of tax | | 0.00 | | 0.00 | ||||||||||
| Trademark amortization, net of tax | | 0.00 | | 0.00 | ||||||||||
| Adjusted diluted earnings (loss) per common share | $ | (0.13 | ) | $ | 0.01 | $ | (0.09 | ) | $ | 0.17 | ||||
Note 4. Derivatives and Hedging
The Company uses certain derivative financial instruments to reduce exposures to volatility of foreign currencies and commodities impacting the costs of its products.
Hedging Foreign Currencies
Certain operating expenses at the Company's Mexican facilities are paid in Mexican pesos. In order to hedge these forecasted cash flows, management purchases forward contracts to buy Mexican pesos for periods and amounts consistent with the related underlying cash flow exposures. These contracts are designated as hedges at inception and monitored for effectiveness on a routine basis. At September 30, 2002, the Company had outstanding forward exchange contracts that mature within approximately fifteen months to purchase Mexican pesos with notional amounts of $65.9 million. The fair values of these contracts at September 30, 2002, totaled $2.9 million, which is recorded as a derivative liability on the Company's balance sheet as other current liabilities. During the next 12 months, approximately $2.7 million of the loss on these contracts could be charged to cost of goods sold. The impact of the changes in fair values of these contracts resulted in other comprehensive loss of $0.3 million and $5.5 million for the three months ended September 30, 2002 and 2001, respectively, and other comprehensive loss of $6.6 million and $0.5 million for the six month periods ended September 30, 2002 and 2001, respectively.
8
Interest Rates Swaps
In April 2002, the Company entered into two interest rate swap contracts (the "Swaps") which effectively converted its $100 million aggregate principal amount of 6.66% senior notes to floating rate debt adjusted semi-annually based on six-month LIBOR plus 1.57% to 1.59%. At September 30, 2002, the fair value of the Swaps, based upon market estimates provided by the counterparties, was approximately $6.9 million and recorded as a derivative asset on the Company's balance sheet as other current assets. These derivative instruments reduced interest expense by approximately $1.0 million for the three and six month periods ended September 30, 2002, respectively, and the mark to market resulted in other income of $3.7 and $5.9 million for the quarter and six month periods ended September 30, 2002, respectively.
All other contracts to purchase raw materials qualify for the normal purchases exclusion and are not accounted for as derivatives.
Note 5. Put Options
The Company sold put options to institutional parties as part of a program to purchase up to 8.0 million of its common shares. Premiums generated from the sale of outstanding put options have been accounted for as Additional Paid-In Capital. The fair value of the put options at September 30, 2002, totaled $1.7 million. The Company had the maximum potential obligation to purchase 300,000 shares of its common stock at a weighted average purchase price of $21.79 ($18.68 net of put premiums received) for an aggregate of $6.5 million at September 30, 2002. The put options are exercisable only at maturity and expire in November 2002. The Company has the right to settle the put options through physical settlement or net share settlement using shares of the Company's common stock.
Note 6. Restructuring and Impairment Charges
On July 8, 2002, the Company announced plans to close one manufacturing facility in Greenwood, SC, and to close one of four manufacturing facilities in Matamoros, Mexico. These actions were part of KEMET's cost saving initiatives over the past year in response to the prolonged downturn in the electronics industry. Restructuring and impairment charges incurred during the quarter ended September 30, 2002, associated with the announcement totaled $17.0 million. The Company reassessed its cost structure resulting in (1) charges of $9.1 million associated with personnel reductions of approximately 185 and 240 employees in the U.S. and Mexico, respectively, and (2) other asset and impairment charges of $7.9 million.
At September 30, 2002, approximatel